BrainsWay Ltd. (BWAY)

Market Cap	298.27M
Revenue (ttm)	49.09M
Net Income (ttm)	6.25M
Shares Out	39.15M
EPS (ttm)	0.13
PE Ratio	47.74
Forward PE	42.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	37,025
Open	14.93
Previous Close	14.78
Day's Range	14.93 - 15.25
52-Week Range	7.84 - 17.92
Beta	0.25
Analysts	Strong Buy
Price Target	20.50 (+35.67%)
Earnings Date	Nov 11, 2025

About BWAY

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves do...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 17, 2019
• Employees: 120
• Stock Exchange: NASDAQ
• Ticker Symbol: BWAY
• Website: https://www.brainsway.com

Analyst Summary

According to 2 analysts, the average rating for BWAY stock is "Strong Buy." The 12-month stock price target is $20.5, which is an increase of 35.67% from the latest price.

Price Target

$20.5

(35.67% upside)

Analyst Consensus: Strong Buy